Sunday, 18 October 20267:35 am ISTIndia edition

सच, सीधे आप तक

Book ad space

Just in

Health

Mankind Pharma to Acquire 70% Stake in Belgian CAR-T Cancer Therapy Developer for €48 Million

Image: Dharmakshethra - India Unabridged. Rights remain with the publisher.

ACTx is developing a new generation of engineered CAR-T cells designed to improve their ability to identify cancer cells, sustain anti-tumour activity and overcome biological mechanisms that allow tumours to resist treatment.

Read the full report on Dharmakshethra - India Unabridged

Story file

Section
Health
Topics
Economy & RBI, Health alerts, Cars & bikes
First reported by
Dharmakshethra - India Unabridged
Reporter
kautilya
Published
Saturday, 17 October 2026, 6:30 pm IST
Coverage
One outlet so far

How this page works. The Headline Update lists this report from Dharmakshethra - India Unabridged with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

Related stories

More Health news

See all